Shingles Vaccine Market Share

Statistics for the 2023 & 2024 Shingles Vaccine market share, created by Mordor Intelligence™ Industry Reports. Shingles Vaccine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Shingles Vaccine Industry

The shingles vaccines market is moderately competitive and consists of a few market players. With technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new vaccines with fewer side effects. Additionally, the key players are involved in strategic alliances, such as product approvals, acquisitions, and collaborations, with companies that complement their product portfolio. Some of the major market players include GSK plc., Merck & Co., Inc., Curevo Inc, Geneone Life Science, SK bioscience, and others.

Shingles Vaccine Market Leaders

  1. Merck & Co., Inc.

  2. Geneone Life Science

  3. SK bioscience

  4. GSK plc

  5. Curevo Inc

*Disclaimer: Major Players sorted in no particular order

Shingles Vaccine Market Concentration

Shingles Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)